Latest Advances

  • Condition: Patent Foramen Ovale (PFO) and Migraine
  • Journal: Journal of the American College of Cardiology
  • Treatment Used: PFO Occluder Device
  • Number of Patients: 337
  • Published —
This study tested the safety and efficacy of using a PFO occluder device to treat patients with PFO and migraines.
  • Condition: Unruptured Intracranial Aneurysms (UIA)
  • Journal: World neurosurgery
  • Treatment Used: Flow Diversion Endovascular Treatment
  • Number of Patients: 38
  • Published —
This study evaluated the effectiveness of flow diversion endovascular treatment (device known as a neurovascular stent placed in the parent blood vessel of a brain aneurysm may divert blood flow away from the aneurysm) in improving headache in patients with unruptured intracranial aneurysms (localized dilations of the cerebral artery walls which are prone to rupture and bleeding; UIA).
  • Condition: Chronic Migraine
  • Journal: Headache
  • Treatment Used: Multiple Cranial Nerve Blocks
  • Number of Patients: 64
  • Published —
The purpose of the study is to evaluate the effectiveness of multiple cranial nerve blocks as a preventive therapy for chronic migraine.
  • Condition: Episodic Migraine Without Aura
  • Journal: BMJ (Clinical research ed.)
  • Treatment Used: Acupuncture
  • Number of Patients: 150
  • Published —
In this study, researchers evaluated the outcomes of using acupuncture for the prevention of episodic migraines without aura.
  • Condition: Acute Severe Encephalopathy Caused by ATP1A2 Mutation of Familial Hemiplegic Migraine Type 2 (FHM2)
  • Journal: Neuropediatrics
  • Treatment Used: Early Treatment Preventing Glutamatergic Excitotoxicity and Protection of Mitochondria Function and Antimigraine Drug
  • Number of Patients: 1
  • Published —
This case report describes a 15-year-old female diagnosed with acute severe encephalopathy caused by ATP1A2 mutation of familial hemiplegic migraine type 2 (FHM2) who underwent early treatment preventing glutamatergic excitotoxicity and protection of mitochondria function and the addition of an antimigraine drug.
  • Condition: Migraine with Aura
  • Journal: Pain research & management
  • Treatment Used: Aurastop vs. Magnesium
  • Number of Patients: 50
  • Published —
This study considered patients suffering from migraines with auras (sensory disturbances preceding migraines) in order to compare the effectiveness of Aurastop versus magnesium as treatments.
  • Condition: Migraine with Aura
  • Journal: Headache
  • Treatment Used: Lamotrigine
  • Number of Patients: 0
  • Published —
This study investigated whether lamotrigine was effective in treating migraines with aura.
Showing 1-7 of 7